Shashank Kulkarni is a seasoned professional in medicinal chemistry with extensive experience in the pharmaceutical industry. Currently serving as Principal Scientist at Nuvalent, Inc. since January 2022, Shashank has previously held roles at EMD Serono, Inc. from January 2017 to January 2022, including Senior Scientist and various research positions. Earlier experience includes valuable contributions as a Research Assistant at the Center for Drug Discovery and the Arkansas Biosciences Institute. Shashank holds a Doctor of Philosophy in Medicinal Chemistry and Drug Discovery from Northeastern University, a Master of Science in Biochemistry from Arkansas State University, and a Bachelor of Science in Chemistry from Alcorn State University.
August, 2024 - present
January, 2022
Principal Scientist at Foghorn Therapeutics
Principal Scientist at Vesigen Therapeutics
Senior Director, Head Of Discovery Chemistry at ATAI Life Sciences
Associate Director, Data Science And AI Operations - R&d at Alcon
Vice President RNA Gene Cell Therapy At Discovery Sciences, Astrazeneca at AstraZeneca
Access the worlds's biggest network of public org charts
Learn more